Skip to main content
pCPA File Number:
21179
Negotiation Status:
Concluded with an LOI
Indication(s):
renal cell carcinoma
Sponsor/Manufacturer:
Merck Canada Inc.
CADTH Project Number:
pCODR 10185
pCPA Engagement Letter Issued:
Negotiation Process Concluded: